Abstract
Purpose
Numerous devices have been developed to warm the eyelid as a therapy for Meibomian gland dysfunction. The optimum temperature for such therapy was determined.
Methods
Meibum lipid disorder versus temperature was calculated from previously published phase transition parameters measured using infrared spectroscopy. Phase transitions parameters were calculated from meibum obtained from donors with Meibomian gland dysfunction (MMGD), donors who were susceptible to dry eye after hematopoietic stem cell transplantations (MHSCT) and meibum from donors without dry eye (Mn).
Results
Heating Mn to 40 °C increases the lipid disorder by 20.4% to 90 %. Heating the meibum another 4 degrees increases the disorder to 95%. MMGD is 73.2 % disordered with no heating. Heating MMGD to 41.5 °C increases the disorder by 26.8 % to 90 % disordered. Heating MMGD another 5.1 °C increases the disorder to 95%. As meibum from donors who had hematopoietic stem cell transplantations, MHSCT, is much more ordered, 56.9 % disordered compared with Mn and MMGD, a higher temperature above safety limits, 52 and 59 °C is need to disorder MHSCT to 90 and 95% disorder.
Conclusions
Heating the eye lid above the phase transition temperature of meibum increases the disorder of meibum lipid which could ameliorate dry eye symptoms. The optimum temperature for disordering Mn and MMGD to 90% maximum disorder is 40 and 41.5 °C, respectively. Safety issues and discomfort should be considered in obtaining an optimal level of disorder, especially for severe cases of dry eye.
Keywords: Dry Eye, Heat Therapy, Infrared Spectroscopy, Meibum, Phase Transition
Introduction
Dry eye affects 5 to 30% of people internationally and meibomian gland dysfunction is the leading cause.1 Meibomian gland dysfunction (MGD) occurs when the meibomian glands become blocked and are incapable of delivering lipid to the tear film surface. Upon blockage, inflammation ensues exasperating dry eye symptoms such as foreign body sensation, itching and burning. Dye eye can lead to visual impairment and reduced quality of life.2,3
Conventional therapy of MGD includes lid expression and massage, thermal treatments and medicinal therapy.4 Elevated eyelid temperature delivers more meibomian oil to the eyelid.5 Numerous devices have been developed to warm the eyelid6–21 and the warming relieves dry eye symptoms,13,15–18,21 improves meibum score,11,15,16 increases tear breakup time,11,15–17 and tear lipid layer thickness14 and ameliorates dry eye related morphological changes in the meibomian gland.11,16–18 One study found that heating did not improve their breakup time or lipid layer thickness.14 Too high of a temperature should be avoided as heat could cause injury to the eyelid skin,22 increase vulnerability to the corneal molding,23,24 and contribute to presbyopia and cataract.25
Insights regarding the effect of temperature on the structure and ‘melting’ of meibum can be gleaned from the most comprehensive study of the phase transition characteristics of meibum that used Fourier transform infrared spectroscopy (FTIR) to follow the order to disorder transition of meibum with temperature.26 FTIR could be used to measure lipid conformation with as little as 0.1 mg of meibum. Conformation is defined as the arrangement of atoms in a molecule that differ by rotation about a single double bond. Hydrocarbon chain conformation is important to the order (fluidity), strength of lipid-lipid interactions, and lipid structure in general. The frequency of the symmetric CH2 stretching band near 2850 cm−1 was used to estimate the trans to gauche rotamer content of the hydrocarbon chains (Fig. 1a and b),27 and it increased with an increase in temperature (Fig. 1c) concurrent with a decrease in intensity.27,28
Figure 1.
a) Infrared spectra of the CH stretching region at 22 )C of a typical 36 year-old Caucasian adolescent female without dry eye (top), and a typical 31 year-old Caucasian adolescent female with dry eye and Hematological Stem Cell Transplantations (bottom). b) Schematic showing trans and gauche conformations in lipid hydrocarbon chains. The greater the number of trans rotamers, the tighter the lipids pack, the stronger the van der Wall’s forces, the greater the lipid order and higher the lipid phase transition temperature.
Copied from citation 26.
Meibum conformation has been measured in human meibum29,30 with age,26,27,31,32 and MGD,26,33,34 dry eye associated with hematopoietic stem cell transplantation26 and to measure the influence of makeup,35 sebum,36 squalene37 and treatment efficacies for dry eye.38,39 Lipid saturation was the major factor that contributed to lipid order and thermodynamics.22,40
The phase transition temperature (Tt) is the temperature where half of the lipids that that undergo a phase transition are melted. The Tt measured by FTIR spectroscopy of meibum from donors without dry eye (Mn) is 30.3 °C, similar to that measured by microscopy,41 32.1 ± 0.1 °C, birefringence,42 32 ± 2 °C, DSC,43 30.2 ± 0.1 °C, reflectance,44 32 ± 1 °C, 34 ± 1.345 and observation 35–40,49 35 – 40 °C,50 32 – 36 °C,51 32–39 °C, and 35–40 °C,46 and 34 ± 1.345 for meibum from patients with MGD (MMGD). The Tt for meibum was slightly lower than that of the surface temperature of the eye, 33.4 °C, and eye lid, 36 °C.47 The Tt increases with MGD26,33,34,46 and decreases with age.26,27,32,32 Elevated % trans rotamers as a result of an increase in Tt and a decrease in cooperativity are likely to cause gross changes in the structure and properties of meibomian films at the air/tear surface in vivo. Ordered lipids may form discontinuous patchy tear film lipid layers which in turn will results in deteriorated spreading,53 decreased surface elasticity and attenuated capability to restore its structure between blinks. This topic has been reviewed.54
In this study, the optimal temperature for melting 90 to 95 % of the meibum lipid was calculated retrospectively from phase transition parameters measured previously.26,34
Methods
Lipid order at a selected temperature was calculated from the average phase transition parameters given in Table 1 using the following equation from citation 26:
Equation 1: |
Table 1.
Phase transition parameters from citation 26.
Source of Meibum | |||
---|---|---|---|
Parameter | Without dry eye | Hematopoietic Stem Cell Transplantations | Meibomian Gland Dysfunction |
Transition Temperature ( °C) | 30.3 ± 0.4 | 34.2 ± 0.9 | 32.2 ± 0.6 |
Cooperativity (Hill coefficient) | 7.9 ± 0.4 | 5.4 ± 0.3 | 9.0 ± 0.4 |
Order 36.0 °C (% trans) | 35 ± 1 | 48 ± 2 | 40 ± 2 |
Order 33.4 °C (% trans) | 40 ± 1 | 54 ± 2 | 44 ± 1 |
Δ enthalpy (kcal/mol) | 142 ± 6 | 121 ± 7 | 153 ± 7 |
Δ entropy (kcal.mol/degree) | 0.48 ± 0.02 | 0.39 ± 0.02 | 0.49 ± 0.02 |
Magnitude (cm −1) | 4.0 ± 0.1 | 4.7 ± 0.5 | 3.8 ± 0.6 |
Minimum Frequency (cm−1) | 2849.71 ± 0.06 | 2849.33 0.06 | 2849.68 ± 0.06 |
Maximum Frequency (cm −1) | 2853.69 ± 0.09 | 2854.00 ± 0.09 | 2853.48 ± 0.08 |
Δ Order 33.4 °C − 36.0 °C (% trans ) | 4.8 ± 0.2 | 5.4 ± 0.2 | 5.9 ± 0.3 |
n | 35 | 23 | 48 |
± standard error of the mean
Where order is % trans rotamers, min is the minimum , max is the maximum , T is the temperature in °C, hill is the relative cooperativity, Tt is the transition temperature in °C. Lipid disorder, % gauche rotamers, at 36 °C, the temperature of the eye lid was calculated from lipid order using the following equation:
Equation 2: |
The % maximum change was calculated by adjusting the disorder scale so that the minimum disorder at about 20 % is 0 % and the maximum disorder at about 80 % is 100 %. Maximum change was calculated from the following equation and plotted versus temperature in Figures 2 B and C:
Equation 3: |
Figure 2.
Human meibum average phase transitions calculated from the parameters in Table 1. ( – ) meibum from donors without dry eye. (---) meibum from donors with meibomian gland dysfunction. ( - ¨ - ) meibum from donors who had hematological stem cell transplantations.
Where disorder is the disorder at a select temperature calculated from equation 2, disorder min is the minimum disorder at the minimum , disorder max is the maximum disorder at maximum .
The temperature at 90 and 95 % maximum disorder was calculated by extrapolation from the curves in Figures 2 B and C.
Collection of Meibum
Meibomian glands were expressed by lightly compressing the eyelids with strict attention to avoid touching the eyelid margin during expression. All four eyelids were expressed, and approximately 0.5 mg of meibum was collected per individual. The expressate was collected with a platinum spatula and dissolved in a vial of chloroform. None of the samples were pooled. Participants were recruited from the Kentucky Lions Eye Center and the James Graham Brown Cancer Center in Louisville, Kentucky. Written informed consent was obtained from all donors and protocols and procedures were approved by the University of Louisville Institutional Review Board Institutional Review Board # 11.0319, August, 2016. All procedures were in accordance with the Declaration of Helsinki.
Diagnosis of Normal and Dry Eye Status
Clinical diagnosis parameters of dry eye can be found in citation 34 as copied briefly below. Normal status was assigned when the patient’s meibomian gland orifices showed no evidence of keratinization or plugging with turbid or normal status was assigned when the patient’s meibomian gland orifices showed no evidence of keratinization or plugging with turbid or thickened secretions, and no dilated blood vessels were observed on the eyelid margin. Normal donors did not recall having dry eye symptoms. Plugging of the meibomian glands in at least 5 of 10 orifices in the central portion of the upper eyelid was a requirement for diagnosis. The character of meibomian gland–expressed secretion had to be turbid, turbid with clumps, or paste like. Inflammation of the eyelid margin, as evidenced by swelling of the eyelid margin and 2+ vascular injection of the posterior lid margin, was necessary for diagnosis. Symptoms were measured on a four-point categorical scale of none, mild, moderate, or severe, according to the subject’s response to questions regarding itching, burning, foreign body sensation, eyelid redness, and eyelid swelling. Signs evaluated were slit lamp–observed conjunctival injection, fluorescein tear breakup time, ocular surface staining with fluorescein, appearance of the eyelid margin, and character of meibomian gland orifices. Donors of MHSCT were diagnosed with MGD and aqueous deficient dry eye based on Schirmer’s strip test.
Results
Lipid disorder begins to increase around 20 °C, where about 20 % of the lipid is disordered. Maximum disorder is reached between 40 and 50 °C, where about 80 % of the lipid is disordered (Fig. 1 A). Table 2 lists the average % of maximum disorder of meibum. Table 2 results are discussed: At 36 °C, the temperature of the meibomian gland, the % maximum lipid disorder of Mn is 79.6. Heating Mn to 40 °C increases the % of maximum lipid disorder by 20.4% to 90 %. Heating the meibum another 4 degrees increases the % of maximum disorder to 95%. MMGD is at 73.2 % of maximum disorder with no heating. Heating MMGD to 41.5 °C increases the % of maximum disorder by 26.8 % to 90 % disordered. Heating MMGD another 5.1 °C increases the % of maximum disorder to 95%. As MHSCT is much less disordered, 56.9 %, compared with Mn and MMGD, higher temperatures, 51.5 and 59 °C are needed to disorder MHSCT to 90 and 95% of maximum disorder, respectively.
Table 2.
Meibum Hydrocarbon Disorder Parameters
Cohort: | No Dry Eye | Meibomian Gland Dysfunction | Hematopoieti Stem Cell Transplantations |
---|---|---|---|
Disorder at 36 °C (% gauche) | 66 ± 2 | 61 ± 2 | 54 ± 3 |
% of Maximum Disorder at 36 °C | 80 ± 2 | 73 ± 2 | 57 ± 3 |
Temperature at 90% Maximum Disorder (°C) | 40 ± 2 | 41 ± 2 | 52 ± 3 |
Temperature at 95% Maximum Disorder (°C) | 44 ± 2 | 45 ± 2 | 59 ± 3 |
Temperature at 66 % Disorder (°C) | 36 ± 2 | 42 ± 2 | 39 ± 3 |
n | 35 | 48 | 23 |
± 90% confidence limit from the Student’s t distribution curve
As Mn is 66.3 % disordered at 36 °C, the temperature necessary for MMGD and MHSCT to reach the disorder level of Mn is 38.5 °C and 42.0 °C.
Discussion
As discussed in the Introduction, heating the eye lid is a therapy for dry eye. The effects of eye lid warming devices on tear film parameters have been reviewed in this journal.55 It is reasonable to speculate that the heating ‘melts’ the meibum lipid, unblocking the meibomian glands and ameliorating the inflammation caused by the blockage. Melting should not be used to describe meibum fluidity changes since melting is associated with a phase change from solid to liquid. However, meibum is not a solid at low temperatures, but in a gel phase that is 20 % disordered. Furthermore, meibum is not a liquid at higher temperatures, but in a liquid crystalline phase that is about 80 % disordered. That is why the physical biochemists use the term ‘gel to liquid crystalline phase transition’ instead of ‘melting’.
The current study suggests the optimum temperatures for disordering Mn and MMGD to 90% maximum disorder is 40 and 41.5 °C, respectively (Table 2). As can be seen in Figure 2, at temperatures near the plateau of disorder there is a minimal increase in disorder with changes in temperature. Heating the meibum another 4 °C above the temperatures listed above only results in 5% more disorder. Given that there is a 5 °C difference in temperature between heat applied on the external eyelid surfaces and that which reaches the inner surface of the lids where the meibum is located,48 to obtain 90 % disorder, the optimal applied heat must be 45 to 46.5 °C at the surface of the eye lid for Mn and MMGD, respectively. At temperatures above 45 °C, discomfort and safety are a factor to consider.22–25 However sub optimal temperatures are still effective since the Tt of meibum is 30 to 32 °C and heating the eye lid to temperatures above the Tt results in significant disordering of the lipid. It should be noted that heating MMGD just 2.5 °C to 38.5 °C disorders MMGD to 66 %, the level of disorder of Mn.
The optimal temperature for disordering MHSCT to 90% maximum disorder is 52 °C (Table 2), so a surface temperature of 57 °C is need. The higher temperature is due to due to a high Tt (34 °C) and broad phase transition due to low cooperativity (Hill coefficient). Discomfort and safety prohibits heating the eye lid surface to the optimal temperature of 57 °C. Perhaps the high temperature needed for severe cases of dry eye, as with MHSCT, could limit the success of heat therapy in this cohort and others. It should be noted that heating MHSCT 6 °C to 42 °C disorders MMGD to 66 %, the level of disorder of Mn.
In conclusion, the current study indicates that heating the eye lid above the Tt of meibum which is 30 to 34 °C, increases the disorder of meibum lipid which could ameliorate dry eye symptoms. Safety issues and discomfort should be considered in obtaining an optimal level of disorder, especially for severe cases of dry eye.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea 2012;31:472–4788. [DOI] [PubMed] [Google Scholar]
- 2.Ishida R, Kojima T, Dogru M, et al. The application of a new continuous functional visual acuity measurement system in dry eye syndromes. Am J Ophthalmol 2005;139:253–258. [DOI] [PubMed] [Google Scholar]
- 3.Koh S Mechanisms of Visual Disturbance in Dry Eye. Cornea 2016;35:S83–S88. [DOI] [PubMed] [Google Scholar]
- 4.Paranjpe DR, Foulks GN. Therapy for meibomian gland disease. Ophthalmol Clin North Am 2003;16:37–42. [DOI] [PubMed] [Google Scholar]
- 5.Nagymihályi A, Dikstein S, Tiffany JM. The influence of eyelid temperature on the delivery of meibomian oil. Exp Eye Res 2004;78:367–70. [DOI] [PubMed] [Google Scholar]
- 6.Kenrick CJ, Alloo SS. The Limitation of Applying Heat to the External Lid Surface: A Case of Recalcitrant Meibomian Gland Dysfunction. Case Rep Ophthalmol 2017;8:7–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Bitton E, Lacroix Z, Léger S. In-vivo heat retention comparison of eyelid warming masks. Cont Lens Anterior Eye 2016;39:311–5. [DOI] [PubMed] [Google Scholar]
- 8.Wang MT, Jaitley Z, Lord SM, Craig JP. Comparison of Self-applied Heat Therapy for Meibomian Gland Dysfunction. Optom Vis Sci 2015;92:e321–6. [DOI] [PubMed] [Google Scholar]
- 9.Murakami DK, Blackie CA, Korb DR. All Warm Compresses Are Not Equally Efficacious. Optom Vis Sci 2015;92:e327–33. [DOI] [PubMed] [Google Scholar]
- 10.Wang MT, Gokul A, Craig JP. Temperature profiles of patient-applied eyelid warming therapies. Cont Lens Anterior Eye 2015;38:430–434. [DOI] [PubMed] [Google Scholar]
- 11.Villani E, Garoli E, Canton V, Pichi F, Nucci P, Ratiglia R. Evaluation of a novel eyelid-warming device in meibomian gland dysfunction unresponsive to traditional warm compress treatment: an in vivo confocal study. Int Ophthalmol 2015;35:319–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lacroix Z, Léger S, Bitton E. Ex vivo heat retention of different eyelid warming masks. Cont Lens Anterior Eye 2015;38:152–156. [DOI] [PubMed] [Google Scholar]
- 13.Doan S, Chiambaretta F, Baudouin C; ESPOIR study group. Evaluation of an eyelid warming device (Blephasteam) for the management of ocular surface diseases in France: the ESPOIR study. J Fr Ophtalmol 2014;37:763–72. [DOI] [PubMed] [Google Scholar]
- 14.Purslow C Evaluation of the ocular tolerance of a novel eyelid-warming device used for meibomian gland dysfunction. Cont Lens Anterior Eye 2013;36:226–31. [DOI] [PubMed] [Google Scholar]
- 15.Greiner JV. A single LipiFlow® Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9 months. Curr Eye Res 2012;37:272–278. [DOI] [PubMed] [Google Scholar]
- 16.Friedland BR, Fleming CP, Blackie CA, Korb DR. A novel thermodynamic treatment for meibomian gland dysfunction. Curr Eye Res 2011;36:79–87. [DOI] [PubMed] [Google Scholar]
- 17.Korb DR1, Blackie CA Restoration of meibomian gland functionality with novel thermodynamic treatment device-a case report. Cornea 2010;29:930–3. [DOI] [PubMed] [Google Scholar]
- 18.Goto E, Monden Y, Takano Y, Mori A, Shimmura S, Shimazaki J, Tsubota K. Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device. Br J Ophthalmol 2002;86:1403–1407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Spiteri A, Mitra M, Menon G, Casini A, Adams D, Ricketts C, Hickling P, Fuller ET, Fuller JR. Tear lipid layer thickness and ocular comfort with a novel device in dry eye patients with and without Sjögren’s syndrome. J Fr Ophtalmol 2007;30:357–364. [DOI] [PubMed] [Google Scholar]
- 20.Mitra M, Menon GJ, Casini A, Hamada S, Adams D, Ricketts C, Fuller ET, Fuller JR. Tear film lipid layer thickness and ocular comfort after meibomian therapy via latent heat with a novel device in normal subjects. Eye (Lond) 2005;19:657–660. [DOI] [PubMed] [Google Scholar]
- 21.Spiteri A, Mitra M, Menon G, Casini A, Adams D, Ricketts C, Hickling P, Fuller ET, Fuller JR. Tear lipid layer thickness and ocular comfort with a novel device in dry eye patients with and without Sjögren’s syndrome. J Fr Ophtalmol 2007;30:357–364. [DOI] [PubMed] [Google Scholar]
- 22.Moritz AR, Henriques FC. Studies of Thermal Injury: II. The Relative Importance of Time and Surface Temperature in the Causation of Cutaneous Burns. Am J Pathol 1947;23:695–720. [PMC free article] [PubMed] [Google Scholar]
- 23.Blackie CA, McMonnies CW, Korb DR. Warm compresses and the risks of elevated corneal temperature with massage. Cornea 2013;32:e146–149. [DOI] [PubMed] [Google Scholar]
- 24.McMonnies CW, Korb DR, Blackie CA. The role of heat in rubbing and massage-related corneal deformation. Cont Lens Anterior Eye 2012;35:148–154. [DOI] [PubMed] [Google Scholar]
- 25.Truscott RJ, Zhu X. Presbyopia and cataract: a question of heat and time. Prog Retin Eye Res 2010;29:487–99. [DOI] [PubMed] [Google Scholar]
- 26.Ramasubramanian A, Blackburn R, Yeo H, Sledge S, Mehta S, Mehta A, Yappert MC, Borchman D. Structural differences in meibum from donors with and without graft versus host disease after hematopoietic stem cell transplantations. Cornea 2019;In Press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Sledge S, Henry C, Borchman D, et al. Human meibum age, lipid-lipid interactions and lipid saturation in meibum from infants. Int J Mol Sci 2017;18:E1862. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Kóta Z, Debreczeny M, Szalontai B. Separable contributions of ordered and disordered lipid fatty acyl chain segments to ṽCH2 bands in model and biological membranes: A Fourier transform infrared spectroscopic study. Biospectroscopy 1999;5:169–178. [DOI] [PubMed] [Google Scholar]
- 29.Borchman D, Foulks GN, Yappert MC, Ho DV. Temperature-induced conformational changes in human tear lipids hydrocarbon chains. Biopolymers 2007;87(2–3):124–133. [DOI] [PubMed] [Google Scholar]
- 30.Borchman D, Foulks GN, Yappert MC, Tang D, Ho DV. Spectroscopic evaluation of human tear lipids. Chem Phys Lipids 2007;147:87–102. [DOI] [PubMed] [Google Scholar]
- 31.Borchman D, Foulks GN, Yappert MC. Confirmation of changes in human meibum lipid infrared spectra with age using principal component analysis. Curr Eye Res 2010;35:778–786. [DOI] [PubMed] [Google Scholar]
- 32.Borchman D, Foulks GN, Yappert MC, et al. Physical changes in human meibum with age as measured by infrared spectroscopy. Ophthalmic Res 2010;44:34–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Borchman D, Foulks GN, Yappert MC. Changes in human meibum lipid with meibomian gland dysfunction using principal component analysis. Exp Eye Res 2010;91:246–256. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Borchman D, Foulks GN, Yappert MC, et al. Human meibum lipid conformation and thermodynamic changes with meibomian-gland dysfunction. Invest Ophthalmol Vis Sci 2011;52:3805–3817. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Hunter M, Bhola R, Yappert MC, Borchman D, Gerlach D. Pilot Study of the Influence of Eyeliner Cosmetics on the Molecular Structure of Human Meibum. Ophthalmic Res 2015;53:131–5. [DOI] [PubMed] [Google Scholar]
- 36.Mudgil P, Borchman D, Gerlach D, Yappert MC. Sebum/Meibum surface film interactions and phase transitional differences. Invest Ophthalmol Vis Sci 2016;57:2401–2411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Borchman D, Yappert MC, Milliner SE, Duran D, Cox GW, Smith RJ, Bhola R. 13C and 1H NMR ester region resonance assignments and the composition of human infant and child meibum. Exp Eye Res 2013;112:151–159. [DOI] [PubMed] [Google Scholar]
- 38.Foulks GN, Borchman D, Yappert MC, Sung-Hye K, McKay JW. Topical Azithromycin Therapy of Meibomian Gland Dysfunction: Clinical response and lipid alterations. Cornea 2010;29:781–788. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Foulks GN, Borchman D, Yappert MC, Kakar S. Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: A comparative clinical and spectroscopic pilot study. Cornea 32:44–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Mudgil P, Borchman D, Yappert MC, et al. Human meibum saturation and lipid order. Exp Eye Res 2013;116:79–85. [DOI] [PubMed] [Google Scholar]
- 41.Butovich IA, Arciniega JC, Wojtowicz JC. Meibomian lipid films and the impact of temperature. Invest Ophthalmol Vis Sci 2010;51:5508–5518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Butovich IA, Lu H, McMahon A, Ketelson H, et al. Biophysical and morphological evaluation of human normal and dry eye meibum using hot stage polarized light microscopy. Invest Ophthalmol Vis Sci 2014;55:87–101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Lu H, Wojtowicz JC, Butovich IA. Differential scanning calorimetric evaluation of human meibomian gland secretions and model lipid mixtures: Transition temperatures and cooperativity of melting. Chem Phys Lipids 2013;170–171:55–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Butovich IA. On the lipid composition of human meibum and tears: Comparative analysis of nonpolar lipids. Invest Ophthalmol Vis Sci 2008;49:3779–3789. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Terada O, Chiba K, Senoo T, Obara Y.[Ocular surface temperature of meibomia gland dysfunction patients and the melting point of meibomian gland secretions]. Nippon Ganka Gakkai Zasshi 2004;108:690–3. [PubMed] [Google Scholar]
- 46.Ong B Meibomian gland dysfunction: some clinical, biochemical and physical observations. Ophthalmic & physiological optics. Journal Brit College Ophthalmic Opticians (Optometrists) 1990;10:144–148. [DOI] [PubMed] [Google Scholar]
- 47.Abreau K, Callan C, Kottaiyan R, et al. Temperatures of the ocular surface, lid, and periorbital regions of Sjögren’s, evaporative, and aqueous-deficient dry eyes relative to normals. Ocul Surf 2016;14:64–73. [DOI] [PubMed] [Google Scholar]
- 48.Blackie CA, Solomon JD, Greiner JV, Holmes M, Korb DR. Inner eyelid surface temperature as a function of warm compress methodology. Optom Vis Sci 2008;85:675–683. [DOI] [PubMed] [Google Scholar]
- 49.Linton RG, Curnow DH, Riley WJ. The Meibomian glands: an investigation into the secretion and some aspects of the physiology. Br J Ophthalmol 1961;45:718–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Brown SI, Dervichian DG. The oils of the meibomian glands: physical and surface characteristics. Arch Ophthalmol 1969;82:537–540. [DOI] [PubMed] [Google Scholar]
- 51.Tiffany JM, Marsden RG. The influence of composition on physical properties of meibomian secretion In The Preocular Tear in Health, Disease and Contact Lens Wear (ed. Holly FJ), Dry Eye Inst., Inc., Lubbock, Texas, pp. 597–608 (1986). [Google Scholar]
- 52.Mori A, Oguchi Y, Goto E, Nakamori K, Ohtsuki T, Egami F, Shimazaki J, Tsubota K. Efficacy and safety of infrared warming of the eyelids. Cornea 1999;18:188–93. [DOI] [PubMed] [Google Scholar]
- 53.Nencheva Y, Ramasubramanian A, Eftimov P, Yokoi N, Borchman D, Georgiev GA. Effects of Lipid Saturation on the Surface Properties of Human Meibum Films. Int J Mol Sci 2018;19:E2209(1–12). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Georgiev GA, Eftimov P, Yokoi N. Structure-function relationship of tear film lipid layer: A contemporary perspective. Exp Eye Res 2017;163:17–28. [DOI] [PubMed] [Google Scholar]
- 55.Arita R, Morishige N, Shirakawa R, Sato Y, Amano S. Effects of Eyelid Warming Devices on Tear Film Parameters in Normal Subjects and Patients with Meibomian Gland Dysfunction. Ocul Surf. 2015. Oct;13(4):321–30. [DOI] [PubMed] [Google Scholar]